01 Apr, 2020
Fields with * are required.
Quidel Corp. (NASDAQ: QDEL) announced today that it has reached an agreement to acquire Alere Inc.'s (NYSE: ALR) Triage B-type Natriuretic Peptide assay business and its Triage MeterPro cardiovascular and toxicology assets for $400 million and $..
Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).